Americas Sleep Apnea Market Key Companies and SWOT Analysis by 2030

Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type (Diagnostic Devices and Therapeutic Devices) and  End User (Hospitals, Homecare Settings, and Others)

  • Report Code : TIPRE00030024
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 136
Buy Now

The Americas sleep apnea market size is expected to grow from US$ 2,454.20 million in 2022 to US$ 4,103.24 million by 2030; the market is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Analyst’s ViewPoint

The Americas sleep apnea market analysis is based on driving factors such as the increasing prevalence of sleep apnea. Further, technological developments would lead to significant future trends in the market during 2022–2030. According to the segmentation considered in the report, in terms of type, the therapeutics segment accounts for a larger share than the diagnostics segment in the Americas sleep apnea market. Among end users, the hospitals segment dominates the market accounting for a maximum share.

Sleep apnea is a potentially serious sleep disorder wherein breathing stops and starts repeatedly. The condition prevents the patient's body from getting enough oxygen. There are two types of sleep apnea: obstructive and central. Common treatments for sleep apnea include breathing devices such as continuous positive air pressure (CPAP) machines and lifestyle changes.

Market Insights

Increasing Prevalence of Sleep Apnea Boosts Market Growth Accounting Considerable Market Share

According to the American Medical Association 2022 report, ~30 million people in the US suffer from sleep apnea. Obstructive sleep apnea (OSA) and central sleep apnea are two types of the disorder. OSA is a serious and life-threatening sleep illness. According to the National Health Sleep Awareness Project survey data published in the American Academy of Sleep Medicine 2023 report, OSA affects 25 million adults in the US. The survey also states that OSA increases the risk of high blood pressure, heart disease, type 2 diabetes, stroke, and depression.

According to the Association of Health Care Journalists report, the treatment of OSA is expensive as it requires overnight stays in sleep labs and hospitals, owing to which it is left untreated among older adults. The investigation was conducted by researchers using a ~5% sample of Medicare administrative claims data from 2006 to 2013. During the investigation, the researchers found that the patient undiagnosed with OSA had more doctor's appointments, emergency room visits, and hospital stays before the beginning of the treatment for the disorder. These untreated patients spend an additional US$ 20,000 annually compared to those diagnosed with OSA. In addition, an American Academy of Sleep Medicine report revealed that the treatment of undiagnosed OSA among the US population costs US$ 149.6 billion annually. Thus, the rising prevalence of sleep apnea is driving the market growth in Americas.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Americas Sleep Apnea Market: Strategic Insights

americas-sleep-apnea-market
Market Size Value inUS$ 2,454.20 million in 2022
Market Size Value byUS$ 4,103.24 million by 2030
Growth rateCAGR of 6.6% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Technological Developments to Bring New Trends in Sleep Apnea Market in Future

Technological advancements and awareness regarding sleep apnea are boosting the adoption of various medical devices, such as PSG and home sleep testing. Many industry players are focusing on innovative product strategies to meet the growing demand for sleep apnea diagnostic devices. For instance, in August 2021, ResMed successfully launched "AirSense 11," the first available in the US. It is the company's next-generation positive airway pressure device designed to assist people suffering from sleep apnea. In August 2020, Nihon Koden Corporation announced the launch of Polysmith 12 polysomnography software. The Polysmith software includes more than 40 market-driven features that allow sleep specialists to improve workflow, analysis, and outcomes of the sleep apnea medical device. The new product also offers a cost-effective design with a broad range of features, such as the enhancement of scheduling, prioritization, and e-mail notification capabilities providing better workflow, improved status tracking to categorize patients based on priority and status, and the ability to track patient progress to improve clinical outcomes.

Report Segmentation and Scope

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Type Insights

Based on type, the Americas sleep apnea market is segmented into diagnostic devices and therapeutic devices. The therapeutic devices segment held a larger market share in 2022, and the diagnostic segment is expected to record a significant CAGR in the Americas sleep apnea market during the forecast period. The market for diagnostic devices is further segmented as polysomnography devices (PSG), home sleep testing devices, pulse oximeters, actigraphy devices, and others. The Americas sleep apnea market for therapeutic devices is subsegmented as PAP, sleep masks, oral appliances, and others. PAP is further categorized as CPAP, APAP, and Bi-PAP.  Sleep apnea may lead to enormous health issues, as most of the population remains undiagnosed. According to a report published by Infosys, ~18 million Americans suffer from moderate to severe OSA, with 85% left undiagnosed. Several manufacturers are developing innovative sleep apnea diagnostic devices. The "NovaSom" technology for the testing of OSA at home works with a proprietary operating system named "MediTrack," which allows a role-based collaboration in compliance with the Health Insurance Portability and Accountability Act (HIPAA) to achieve integrated patient care. This innovative diagnostic solution enables cost reduction and improves testing speed, accuracy, and efficiency.

End User Insights

Based on end user, the Americas sleep apnea market is segregated into hospitals, homecare settings, and others. The hospitals segment accounted for the largest market share in 2022, and the homecare segment is expected to register the highest CAGR during the forecast period. Hospitals are more well-equipped and specialized than sleep centers; hence, more sophisticated sleep studies can be organized in hospital facilities. Some of these hospital facilities are associated with sleep labs touted as accredited centers. Similarly, sleep laboratories either operate individually or in collaboration with hospitals. For treating sleep apnea cases, hospitals in the Americas mainly follow the standards recommended by regulatory authorities such as the American Academy of Sleep Centers. The widespread presence of hospitals, and convenient availability of both diagnostic and treatment solutions at one location results in high in-patient admissions in these facilities. Several procedures in hospitals are also eligible for insurance reimbursement.

Americas Sleep Apnea Market, by Type – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Country Analysis

The Americas sleep apnea market is segmented into the US, Canada, Mexico, Brazil, Argentina, Chile, Peru, Colombia, and Rest of the Americas. The market growth in the region is driven by the rising geriatric population and growing awareness about the ill effects of snoring.

Sleep apnea is one of the major health issues and a common sleep disorder in the US. The American Sleep Apnea Association estimates that 38,000 people in the country die each year from heart disease with sleep apnea as a complication. In addition to the increasing number of deaths associated with the disease and the rising awareness about the related risk factors, the growing importance of sleep testing in adults and pediatric populations favors the sleep apnea market growth. Excessive daytime sleepiness among people with narcolepsy or OSA at work, at home, or in daily activities hampers their daily lives. In March 2019, Jazz Pharmaceuticals plc received US Food and Drug Administration (FDA) approval for its product named "Sunosi" (Solriamfetol), prescribed to improve wakefulness among adult patients suffering from excessive daytime sleepiness associated with narcolepsy or OSA. The increasing availability of such medicines bolsters the growth of sleep apnea in the US.

The Canadian market exhibits potential growth opportunities with an increase in the importance of diagnosis and treatment of chronic as well as acute diseases. The rapidly developing medical device sector and the proliferation of the healthcare sector are other factors that influence the sleep apnea market progress in the country. The prevalence of sleep apnea is increasing in Canada. As per the Breathe, the Canadian Lung Association, 26% of Canadian adults aged 18 or more are at a high risk of sleep apnea. It is one of the underdiagnosed respiratory diseases in the country. Continued positive airway pressure (CPAP) therapy is the most common intervention prescribed for patients with sleep apnea. The Assistive Devices Program by the Ministry of Health and Long-Term Care, covers the cost of CPAP machines and equipment in Canada, while organizations such as Canadian Home Care Setting Inc. provide financial assistance for the purchase of CPAP. In January 2018, the Winnipeg Regional Health Authority announced new copayment models for CPAP therapy equipment, which came into effect in April 2018. With this model, the new and replacement CPAP machines would cost patients US$ 500. The copayment model is likely to lead to the saving of nearly US$ 4.9 million per year for the Canadian health authority.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, and  End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the Americas sleep apnea market across the globe?

Increasing prevalence of sleep apnea is a standalone factor responsible for the overall market growth.

What is meant by the Americas sleep apnea market?

Sleep apnea is a potentially serious sleep disorder where breathing repeatedly stops and starts. Such a condition prevents the patient's body from getting enough oxygen. There are two types of sleep apnea: obstructive and central. Common sleep apnea treatments include breathing devices such as continuous positive air pressure (CPAP) machines and lifestyle changes.

Who are the key players in the Americas sleep apnea market?

ResMed Inc, Nihon Kohden Corp, Fisher & Paykel Healthcare Ltd, Koninklijke Philips NV, Cadwell Industries Inc, Natus Medical Inc, Compumedics Limited, LivaNova Plc, Invacare Corp, and Braebon Medical Corporation among others are among the leading companies operating in the Americas sleep apnea market.

Which segment led the Americas sleep apnea market?

Based on type, the therapeutic device segment took the forefront lead in the Americas sleep apnea market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

Which end user segment held the largest revenue (US$ Mn) in the Americas sleep apnea market?

The hospitals segment dominated the global Americas sleep apnea market and accounted for the largest revenue in 2022.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Americas Sleep Apnea Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Americas Sleep Apnea Market – Market Landscape

4.1 Overview

4.1.1 Americas PEST Analysis

5. Sleep Apnea Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Sleep Apnea

5.1.2 Growing Demand for Sleep Apnea Diagnostic Devices and Therapeutic Solutions

5.2 Market Restraints

5.2.1 Low Awareness of Sleep Apnea

5.3 Market Opportunities

5.3.1 Innovative Product Launches and Clinical Trials

5.4 Future Trends

5.4.1 Technological Developments

5.5 Impact Analysis

6. Americas Sleep Apnea Market – Regional Analysis

6.1 Americas Sleep Apnea Market Revenue Forecast and Analysis

7. Americas Sleep Apnea Market – Revenue and Forecast to 2030 – by Type

7.1 Overview

7.2 Americas Sleep Apnea Market Revenue Share, by Type 2022 & 2030 (%)

7.3 Diagnostic Devices

7.3.1 Overview

7.3.2 Diagnostic Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.3.3 Polysomnography Devices (PSG)

7.3.3.1 Overview

7.3.3.2 Polysomnography Devices (PSG): Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.3.4 Home Sleep Testing Devices

7.3.4.1 Overview

7.3.4.2 Home Sleep Testing Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.3.5 Pulse Oximeters

7.3.5.1 Overview

7.3.5.2 Pulse Oximeters: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.3.6 Actigraphy Devices

7.3.6.1 Overview

7.3.7 Actigraphy Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.3.8 Others

7.3.8.1 Overview

7.3.9 Others: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4 Therapeutic Devices

7.4.1 Overview

7.4.2 Therapeutic Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.3 PAP

7.4.3.1 Overview

7.4.3.2 PAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.3.3 CPAP

7.4.3.3.1 Overview

7.4.3.3.2 CPAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.3.4 APAP

7.4.3.4.1 Overview

7.4.3.4.2 APAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.3.5 Bi-PAP

7.4.3.5.1 Overview

7.4.3.5.2 Bi-PAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.4 Sleep Masks

7.4.4.1 Overview

7.4.4.2 Sleep Masks: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.5 Oral Appliances

7.4.5.1 Overview

7.4.5.2 Oral Appliances: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

8. Americas Sleep Apnea Market Analysis and Forecasts to 2028 – by End User

8.1 Overview

8.2 Americas Sleep Apnea Market, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Homecare Settings

8.4.1 Overview

8.4.2 Homecare Settings: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

9. Americas Sleep Apnea Market – Revenue and Forecast to 2030 – Geographic Analysis

9.1 Americas Sleep Apnea Market, Revenue and Forecast to 2030

9.1.1 Overview

9.1.2 Americas Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.1 Americas Sleep Apnea Market, by Type

9.1.2.2 Americas Sleep Apnea Market, by Diagnostic Devices

9.1.2.3 Americas Sleep Apnea Market, by Therapeutic Devices

9.1.2.3.1 Americas Sleep Apnea Market, by PAP

9.1.2.4 Americas Sleep Apnea Market, by End User

9.1.2.5 Americas Sleep Apnea Market by Country

9.1.2.6 US

9.1.2.6.1 Overview

9.1.2.6.2 US Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.7 US Sleep Apnea Market, by Type

9.1.2.7.1 US Sleep Apnea Market, by Diagnostic Devices

9.1.2.7.2 US Sleep Apnea Market, by Therapeutic Devices

9.1.2.7.2.1 US Sleep Apnea Market, by PAP

9.1.2.8 US Sleep Apnea Market, by End User

9.1.2.9 Canada

9.1.2.9.1 Overview

9.1.2.9.2 Canada Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.10 Canada Sleep Apnea Market, by Type

9.1.2.10.1 Canada Sleep Apnea Market, by Diagnostic Devices

9.1.2.10.2 Canada Sleep Apnea Market, by Therapeutic Devices

9.1.2.10.2.1 Canada Sleep Apnea Market, by PAP

9.1.2.11 Canada Sleep Apnea Market, by End User

9.1.2.12 Mexico

9.1.2.12.1 Overview

9.1.2.12.2 Mexico Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.13 Mexico Sleep Apnea Market, by Type

9.1.2.13.1 Mexico Sleep Apnea Market, by Diagnostic Devices

9.1.2.13.2 Mexico Sleep Apnea Market, by Therapeutic Devices

9.1.2.13.2.1 Mexico Sleep Apnea Market, by PAP

9.1.2.14 Mexico Sleep Apnea Market, by End User

9.1.2.15 Brazil

9.1.2.15.1 Overview

9.1.2.15.2 Brazil Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.16 Brazil Sleep Apnea Market, by Type

9.1.2.16.1 Brazil Sleep Apnea Market, by Diagnostic Devices

9.1.2.16.2 Brazil Sleep Apnea Market, by Therapeutic Devices

9.1.2.16.2.1 Brazil Sleep Apnea Market, by PAP

9.1.2.17 Brazil Sleep Apnea Market, by End User

9.1.2.18 Argentina

9.1.2.18.1 Overview

9.1.2.18.2 Argentina Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.19 Argentina Sleep Apnea Market, by Type

9.1.2.19.1 Argentina Sleep Apnea Market, by Diagnostic Devices

9.1.2.19.2 Argentina Sleep Apnea Market, by Therapeutic Devices

9.1.2.19.2.1 Argentina Sleep Apnea Market, by PAP

9.1.2.20 Argentina Sleep Apnea Market, by End User

9.1.2.21 Chile

9.1.2.21.1 Overview

9.1.2.21.2 Chile Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.22 Chile Sleep Apnea Market, by Type

9.1.2.22.1 Chile Sleep Apnea Market, by Diagnostic Devices

9.1.2.22.2 Chile Sleep Apnea Market, by Therapeutic Devices

9.1.2.22.2.1 Chile Sleep Apnea Market, by PAP

9.1.2.23 Chile Sleep Apnea Market, by End User

9.1.2.24 Peru

9.1.2.24.1 Overview

9.1.2.24.2 Peru Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.25 Peru Sleep Apnea Market, by Type

9.1.2.25.1 Peru Sleep Apnea Market, by Diagnostic Devices

9.1.2.25.2 Peru Sleep Apnea Market, by Therapeutic Devices

9.1.2.25.2.1 Peru Sleep Apnea Market, by PAP

9.1.2.26 Peru Sleep Apnea Market, by End User

9.1.2.27 Colombia

9.1.2.27.1 Overview

9.1.2.27.2 Colombia Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.28 Colombia Sleep Apnea Market, by Type

9.1.2.28.1 Colombia Sleep Apnea Market, by Diagnostic Devices

9.1.2.28.2 Colombia Sleep Apnea Market, by Therapeutic Devices

9.1.2.28.2.1 Colombia Sleep Apnea Market, by PAP

9.1.2.29 Colombia Sleep Apnea Market, by End User

9.1.2.30 Rest of Americas

9.1.2.30.1 Overview

9.1.2.30.2 Rest of Americas Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)

9.1.2.31 Rest of Americas Sleep Apnea Market, by Type

9.1.2.31.1 Rest of Americas Sleep Apnea Market, by Diagnostic Devices

9.1.2.31.2 Rest of Americas Sleep Apnea Market, by Therapeutic Devices

9.1.2.31.2.1 Rest of Americas Sleep Apnea Market, by PAP

9.1.2.32 Rest of Americas Sleep Apnea Market, by End User

10. Pre and Post COVID-19 Impact

10.1 Pre and Post COVID-19 Impact

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 ResMed Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Nihon Kohden Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Fisher & Paykel Healthcare Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Koninklijke Philips NV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Cadwell Industries Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Natus Medical Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Compumedics Limited

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 LivaNova Plc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Invacare Corp

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Braebon Medical Corporation

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.11 Financial Overview

12.11.1 SWOT Analysis

12.11.2 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 2. Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 3. Americas Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 4. Americas Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 5. Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 7. US Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 8. US Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 9. US Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 10. US Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 11. US Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 12. Canada Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 13. Canada Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 14. Canada Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 15. Canada Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 16. Canada Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 17. Mexico Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 18. Mexico Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 19. Mexico Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 20. Mexico Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 21. Mexico Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 22. Brazil Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 23. Brazil Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 24. Brazil Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 25. Brazil Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 26. Brazil Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 27. Argentina Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 28. Argentina Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 29. Argentina Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 30. Argentina Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 31. Argentina Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 32. Chile Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 33. Chile Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 34. Chile Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 35. Chile Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 36. Chile Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 37. Peru Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 38. Peru Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 39. Peru Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 40. Peru Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 41. Peru Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 42. Colombia Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 43. Colombia Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 44. Colombia Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 45. Colombia Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 46. Colombia Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 47. Rest of Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Type

Table 48. Rest of Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – Diagnostic Devices

Table 49. Rest of Americas Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – Therapeutic Devices

Table 50. Rest of Americas Sleep Apnea Market Revenue And Forecast To 2030 (US$ Mn) – PAP

Table 51. Rest of Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 52. Organic Developments Done by Companies

Table 53. Inorganic Developments Done by Companies

Table 54. Glossary of Terms

List of Figures

Figure 1. Sleep Apnea Market Segmentation

Figure 2. Sleep Apnea Market, by Region

Figure 3. Key Insights

Figure 4. Americas : PEST Analysis

Figure 5. Sleep Apnea Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 6. Americas Sleep Apnea Market – Revenue Forecast and Analysis – 2020–2030

Figure 7. Americas Sleep Apnea Market Revenue Share, by Type 2022 & 2030 (%)

Figure 8. Diagnostic Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. Polysomnography Devices (PSG): Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. Home Sleep Testing Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11. Pulse Oximeters: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12. Actigraphy Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. Others: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14. Therapeutic Devices: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15. PAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16. CPAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17. APAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18. Bi-PAP: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19. Sleep Masks: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20. Oral Appliances: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21. Others: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22. Americas Sleep Apnea Market, by End User 2022 & 2030 (%)

Figure 23. Hospitals: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24. Homecare Settings: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25. Others: Americas Sleep Apnea Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26. Americas Sleep Apnea Market, By Region, 2022 ($Mn)

Figure 27. Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 28. Americas Sleep Apnea Market, By Key Countries, 2022 And 2030 (%)

Figure 29. US Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 30. Canada Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 31. Mexico Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 32. Brazil Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 33. Argentina Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 34. Chile Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 35. Peru Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 36. Colombia Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 37. Rest of Americas Sleep Apnea Market Revenue And Forecast to 2030 (US$ Mn)

Figure 38. Pre and Post COVID-19 Impact on Americas Sleep Apnea Market

The List of Companies - Americas Sleep Apnea Market

  1. ResMed Inc            
  2. Nihon Kohden Corp            
  3. Fisher & Paykel Healthcare Ltd       
  4. Koninklijke Philips NV        
  5. Cadwell Industries Inc        
  6. Natus Medical Inc               
  7. Compumedics Limited       
  8. LivaNova Plc          
  9. Invacare Corp        
  10. Braebon Medical Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Americas Sleep Apnea Market